ArticleScientific reports2024
Nationwide study of chronic codeine use and its impact on cough related diseases in South Korea.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Clinical validation of the Rapid Cough Questionnaire across diverse lung diseases.BMJ open respiratory research · 2026Article
- Objective Assessment of the Cough: Listening to the Patient's Voice. A Narrative Review.Tuberculosis and respiratory diseases · 2026Article
- Cough Assessment in Chronic Respiratory Diseases (COASESS): Findings from a Prospective Multicenter Cross-Sectional Study.Tuberculosis and respiratory diseases · 2026Article
- Astrocytes and Astrocyte-Derived Extracellular Conduits in Opiate-Mediated Neurological Disorders.Cells · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Codeine is widely used to control coughs, although concerns about its overuse arise due to its side-effects. This study aimed to evaluate the status of codeine usage according to various medical conditions. The Korean National Health Insurance Service sample cohort was analyzed. Subjects with more than continuous sixty days of antitussive and codeine were defined as chronic users. It was evaluated according to age, smoking status, chronic obstructive pulmonary disease (COPD), asthma, allergic rhinitis (AR), bronchiectasis, chronic cough (CC), gastroesophageal reflux disease (GERD), and lung cancer. A total of 89,289 chronic antitussive users were identified, of whom 589 were chronic codeine users. The chronic codeine users were older, more likely to be smokers, and more likely to have multimorbidity (P < 0.001, all). After adjusting age, chronic codeine use showed a positive correlation with lung cancer (adjusted odds ratio [aOR]: 6.99), COPD (aOR: 2.04), GERD (aOR: 1.93), and CC (aOR: 1.60). Multimorbidity also revealed positive correlations, increasing as the number of comorbidities rose (P < 0.001). Our findings highlight that chronic codeine usage is associated with underlying cough-inducing diseases, emphasizing the need for monitoring and guidelines to ensure safer use, especially among older adults and those with chronic respiratory conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.